FDMT vs VMC · rev $37.0K vs P/E 35, rev $7.42B
4D Molecular Therapeutics Inc (FDMT) versus Vulcan Materials Company (VMC) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Vulcan Materials Company (VMC) is a building materials company listed on NYSE.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
Latest reported VMC revenue for 2024-12-31 was $7.42B. Net income was $913.1M. Revenue was down 4.7% from 2023-12-31 to 2024-12-31. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
FDMT currently screens at market cap $518.1M. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
Not investment advice. Open the FDMT and VMC stock pages for the full models.
Not investment advice.